190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
12 mai 2020 08h05 HE | BioNTech SE
Global Phase 1/2 clinical trial for BNT162 vaccine program to prevent COVID-19 infection in dose escalation phase in Europe and the U.S.; first cohorts dosed in both regionsBNT122 Phase 1/2 trial...
Incap Group’s Busine
Incap Group’s Business Review for January–March 2020: Profitability on a good level despite the negative impact of the pandemic
12 mai 2020 01h30 HE | Incap Corporation:
Incap Corporation                                                 Stock Exchange Release Business Review Q1 2020                              12 May 2020 at 8.30 a.m. (EET)  Incap Group’s...
ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
11 mai 2020 05h34 HE | ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, May 11, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative...
DFDS A/S: DELÅRSRAPP
DFDS A/S: DELÅRSRAPPORT 1. KVT. 2020
07 mai 2020 02h19 HE | DFDS A/S
Selskabsmeddelelse nr. 12/2020   Håndtering af Covid-19 • Kortsigtet fokus på at begrænse påvirkning af indtjening og likviditet • Alle fragtaktiviteter i fortsat drift • Finansiel...
DFDS A/S: Q1 2020 In
DFDS A/S: Q1 2020 Interim Report
07 mai 2020 02h19 HE | DFDS A/S
Company announcement no. 12/2020 Managing through Covid-19 • Short term focus on mitigating earnings and cash impacts • All freight activities continue...
intrepidlogoa01.jpg
Intrepid Announces First Quarter 2020 Results
06 mai 2020 16h30 HE | Intrepid Potash, Inc
DENVER, CO, May 06, 2020 (GLOBE NEWSWIRE) --  - Intrepid Potash, Inc. (Intrepid) (NYSE:IPI) today reported its results for the first quarter of 2020. Please note a change in the conference call...
IOSP Logo.jpg
Innospec Reports First Quarter 2020 Financial Results
05 mai 2020 16h45 HE | Innospec Inc.
Liquidity maintained by positive operating cash flow and conservative cash managementIncrease in GAAP EPS of 15 percent; Adjusted non-GAAP EPS up 14 percentGAAP EPS $1.34 and adjusted EPS of $1.42...
190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
BioNTech veröffentlicht am 12. Mai 2020 Ergebnisse des ersten Quartals 2020 sowie Informationen zum operativen Fortschritt
05 mai 2020 06h00 HE | BioNTech SE
MAINZ, Deutschland, May 05, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech”) wird am Dienstag, den 12. Mai 2020, die Ergebnisse des ersten Quartals 2020 veröffentlichen. BioNTech wird...
190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020
05 mai 2020 06h00 HE | BioNTech SE
MAINZ, Germany, May 05, 2020 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) will announce its financial results for the first quarter 2020 on Tuesday, May 12th, 2020. BioNTech will also...